Longevity
NAD+
Also called NAD+, NMN
per administration
It has been used in people, but no trial has settled how much or how often.
Quick start
NAD+ at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–500 mg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~3 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Structure note
A diagram is a reference representation of the named chemical structure. It does not establish the composition, purity, or identity of any particular vial.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for NAD+ describe 100–500 mg per administration. Descriptive only, not a recommendation.
A cofactor rather than a peptide; its precursors turn over rapidly and a single decay figure does not describe it well.
A cofactor (nicotinamide adenine dinucleotide) and its precursor NMN, catalogued here because people group them with peptides though neither is one. Reported amounts vary widely by route — intravenous infusions, subcutaneous injections and oral precursors are all in circulation — and no single dose-ranging trial fixes a schedule, so the figure above is a nominal placeholder and no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- NAD+/NMN precursor literatureHuman work covers oral NMN and NR and intravenous NAD+ infusions; amounts vary by route and are not fixed by a dose-ranging trial.